Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer von MAKI, Robert G

Volltext

Flashback Foreword: Kinase Mutations and Imatinib Response in Patients With Metastatic GI Stromal Tumor von Maki, Robert G.

Volltext

Flashback Foreword: Single-Agent Anti-Programmed Cell Death Protein 1 Therapy for Refractory Solid Tumors von Maki, Robert G

Volltext

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial von Tawbi, Hussein A, Burgess, Melissa, Bolejack, Vanessa, Van Tine, Brian A, Schuetze, Scott M, Hu, James, D'Angelo, Sandra, Attia, Steven, Riedel, Richard F, Priebat, Dennis A, Movva, Sujana, Davis, Lara E, Okuno, Scott H, Reed, Damon R, Crowley, John, Butterfield, Lisa H, Salazar, Ruth, Rodriguez-Canales, Jaime, Lazar, Alexander J, Wistuba, Ignacio I, Baker, Laurence H, Maki, Robert G, Reinke, Denise, Patel, Shreyaskumar

Volltext

The Weighted Toxicity Score: Confirmation of a Simple Metric to Communicate Toxicity in Randomized Trials of Systemic Cancer Therapy von Jordan, Jacob, Maki, Robert G

Volltext

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial von Schöffski, Patrick, Prof, Chawla, Sant, MD, Maki, Robert G, Prof, Italiano, Antoine, MD, Gelderblom, Hans, Prof, Choy, Edwin, MD, Grignani, Giovanni, MD, Camargo, Veridiana, MD, Bauer, Sebastian, MD, Rha, Sun Young, MD, Blay, Jean-Yves, Prof, Hohenberger, Peter, MD, D'Adamo, David, MD, Guo, Matthew, PhD, Chmielowski, Bartosz, MD, Le Cesne, Axel, MD, Demetri, George D, Prof, Patel, Shreyaskumar R, Prof

Volltext

Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition von Pang, Angela, Carbini, Mariana, Moreira, Andre L, Maki, Robert G

Volltext

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multice... von Demetri, George D, von Mehren, Margaret, Jones, Robin L, Hensley, Martee L, Schuetze, Scott M, Staddon, Arthur, Milhem, Mohammed, Elias, Anthony, Ganjoo, Kristen, Tawbi, Hussein, Van Tine, Brian A, Spira, Alexander, Dean, Andrew, Khokhar, Nushmia Z, Park, Youn Choi, Knoblauch, Roland E, Parekh, Trilok V, Maki, Robert G, Patel, Shreyaskumar R

Volltext

Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model von Demicco, Elizabeth G, Wagner, Michael J, Maki, Robert G, Gupta, Vishal, Iofin, Ilya, Lazar, Alexander J, Wang, Wei-Lien

Volltext

Malignant Peripheral Nerve Sheath Tumors von Farid, Mohamad, Demicco, Elizabeth G., Garcia, Roberto, Ahn, Linda, Merola, Pamela R., Cioffi, Angela, Maki, Robert G.

Volltext

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-... von Demetri, George D, Prof, Reichardt, Peter, Prof, Kang, Yoon-Koo, Prof, Blay, Jean-Yves, Prof, Rutkowski, Piotr, MD, Gelderblom, Hans, MD, Hohenberger, Peter, Prof, Leahy, Michael, FRCP, von Mehren, Margaret, Prof, Joensuu, Heikki, Prof, Badalamenti, Giuseppe, MD, Blackstein, Martin, FRCP, Le Cesne, Axel, MD, Schöffski, Patrick, Prof, Maki, Robert G, Prof, Bauer, Sebastian, MD, Nguyen, Binh Bui, MD, Xu, Jianming, MD, Nishida, Toshirou, MD, Chung, John, MD, Kappeler, Christian, PhD, Kuss, Iris, MD, Laurent, Dirk, MD, Casali, Paolo G, MD

Volltext

Flashback Foreword: Prognostic Factors in Osteosarcoma von Maki, Robert G., Schwartz, Gary K.

Volltext

Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment von Khan, Jalal A, Maki, Robert G, Ravi, Vinod

Volltext

GI Stromal Tumors: 15 Years of Lessons From a Rare Cancer von Cioffi, Angela, Maki, Robert G

Volltext

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma von Davis, Lara E, Bolejack, Vanessa, Ryan, Christopher W, Ganjoo, Kristen N, Loggers, Elizabeth T, Chawla, Sant, Agulnik, Mark, Livingston, Michael B, Reed, Damon, Keedy, Vicky, Rushing, Daniel, Okuno, Scott, Reinke, Denise K, Riedel, Richard F, Attia, Steven, Mascarenhas, Leo, Maki, Robert G

Volltext

Brightline-1: phase II/III trial of the MDM2–p53 antagonist BI 907828 versus doxorubicin in patients with advanced DDLPS von Schöffski, Patrick, Lahmar, Mehdi, Lucarelli, Anthony, Maki, Robert G

Volltext

Flashback Foreword: Carboplatin Dosage Based on Renal Function von Maki, Robert G., Cannistra, Stephen A.

Volltext

Advances in sarcoma genomics and new therapeutic targets von Ladanyi, Marc, Taylor, Barry S, Barretina, Jordi, Maki, Robert G, Antonescu, Cristina R, Singer, Samuel

Volltext

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis von Shaw, Alice T, Dr, Yeap, Beow Y, ScD, Solomon, Benjamin J, MD, Riely, Gregory J, MD, Gainor, Justin, MD, Engelman, Jeffrey A, MD, Shapiro, Geoffrey I, MD, Costa, Daniel B, MD, Ou, Sai-Hong I, MD, Butaney, Mohit, BS, Salgia, Ravi, Prof, Maki, Robert G, MD, Varella-Garcia, Marileila, Prof, Doebele, Robert C, MD, Bang, Yung-Jue, Prof, Kulig, Kimary, PhD, Selaru, Paulina, MSPH, Tang, Yiyun, PhD, Wilner, Keith D, PhD, Kwak, Eunice L, MD, Clark, Jeffrey W, MD, Iafrate, A John, MD, Camidge, D Ross, MD

Volltext

A framework for advancing our understanding of cancer-associated fibroblasts von Sahai, Erik, Astsaturov, Igor, Cukierman, Edna, DeNardo, David G., Egeblad, Mikala, Evans, Ronald M., Fearon, Douglas, Greten, Florian R., Hingorani, Sunil R., Hunter, Tony, Hynes, Richard O., Jain, Rakesh K., Janowitz, Tobias, Jorgensen, Claus, Kimmelman, Alec C., Kolonin, Mikhail G., Maki, Robert G., Powers, R. Scott, Puré, Ellen, Ramirez, Daniel C., Scherz-Shouval, Ruth, Sherman, Mara H., Stewart, Sheila, Tlsty, Thea D., Tuveson, David A., Watt, Fiona M., Weaver, Valerie, Weeraratna, Ashani T., Werb, Zena

Volltext